#ICH
3 Threads
🧵Thread on the ANNEXA trials for reversing DOAC-related bleeds 🩸 As #DOAC (FXa inhibitors) have increasingly replaced VKAs, let’s discuss the development and study of their revers...
1) Welcome to a 🆕#LIVE #accredited #tweetorial from #Basel 🇨🇭 & #ESOC2024, where we have just seen a new secondary analysis of #ANNEXa_I, the FIRST randomized comparison #andexanet...
Here are some key points from @American_Heart updated 2022 ICH guidelines:🩸🧠 1⃣ Most common causes: i) arteriolosclerosis ii) CAA (often co-occurring). CAA⬆️recurrence rates 2⃣ Pr...